BioMark Diagnostics Inc. (BUX.CN)
CAD 0.2
(0.0%)
CAD 0.2
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.02 CAD | 25.11% |
| 2022 | -0.02 CAD | -10.95% |
| 2021 | -0.02 CAD | -34.9% |
| 2020 | -0.01 CAD | 12.35% |
| 2019 | -0.02 CAD | -104.82% |
| 2018 | -0.01 CAD | 30.83% |
| 2017 | -0.01 CAD | 9.09% |
| 2016 | -0.01 CAD | 53.19% |
| 2015 | -0.03 CAD | 74.36% |
| 2014 | -0.11 CAD | -198.1% |
| 2013 | -0.04 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.01 CAD | -60.47% |
| 2023 FY | - CAD | 25.11% |
| 2023 Q2 | -0.00 CAD | 50.0% |
| 2023 Q1 | -0.01 CAD | 16.67% |
| 2023 Q3 | -0.00 CAD | -92.0% |
| 2023 Q4 | -0.00 CAD | 10.42% |
| 2022 Q1 | -0.01 CAD | 33.77% |
| 2022 FY | - CAD | -10.95% |
| 2022 Q4 | -0.01 CAD | -25.0% |
| 2022 Q3 | -0.00 CAD | 23.81% |
| 2022 Q2 | -0.01 CAD | -23.53% |
| 2021 Q2 | -0.00 CAD | 37.5% |
| 2021 FY | - CAD | -34.9% |
| 2021 Q4 | -0.01 CAD | -102.63% |
| 2021 Q3 | -0.00 CAD | -52.0% |
| 2021 Q1 | -0.00 CAD | 50.62% |
| 2020 FY | - CAD | 12.35% |
| 2020 Q4 | -0.01 CAD | -200.0% |
| 2020 Q2 | -0.00 CAD | -44.44% |
| 2020 Q3 | -0.00 CAD | -3.85% |
| 2020 Q1 | -0.00 CAD | 55.0% |
| 2019 Q3 | -0.01 CAD | -390.0% |
| 2019 Q4 | -0.00 CAD | 59.18% |
| 2019 FY | - CAD | -104.82% |
| 2019 Q1 | -0.00 CAD | 0.0% |
| 2019 Q2 | -0.00 CAD | -11.11% |
| 2018 FY | - CAD | 30.83% |
| 2018 Q4 | -0.00 CAD | 33.33% |
| 2018 Q3 | -0.00 CAD | -3.85% |
| 2018 Q1 | -0.00 CAD | 25.0% |
| 2018 Q2 | -0.00 CAD | -44.44% |
| 2017 Q3 | -0.00 CAD | 21.05% |
| 2017 FY | - CAD | 9.09% |
| 2017 Q1 | -0.00 CAD | 22.73% |
| 2017 Q2 | -0.00 CAD | -11.76% |
| 2017 Q4 | -0.00 CAD | 20.0% |
| 2016 Q1 | -0.00 CAD | 70.8% |
| 2016 FY | - CAD | 53.19% |
| 2016 Q4 | -0.00 CAD | -109.52% |
| 2016 Q3 | -0.00 CAD | 25.0% |
| 2016 Q2 | -0.00 CAD | 30.0% |
| 2015 FY | - CAD | 74.36% |
| 2015 Q1 | -0.01 CAD | 70.22% |
| 2015 Q3 | -0.01 CAD | -12.77% |
| 2015 Q4 | -0.01 CAD | -158.49% |
| 2015 Q2 | -0.00 CAD | 29.85% |
| 2014 FY | - CAD | -198.1% |
| 2014 Q3 | -0.07 CAD | -580.21% |
| 2014 Q4 | -0.02 CAD | 65.54% |
| 2014 Q2 | -0.01 CAD | 16.52% |
| 2014 Q1 | -0.01 CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Izotropic Corporation | -0.03 CAD | 42.414% |
| Sona Nanotech Inc. | -0.03 CAD | 42.612% |